Smith JR - Search Results

1

Safety profile of oseltamivir during the 2009 influenza pandemic.

Donner B, Bader-Weder S, Schwarz R, Peng MM, Smith JR, Niranjan V. Donner B, et al. Among authors: smith jr. Pharmacoepidemiol Drug Saf. 2011 May;20(5):532-43. doi: 10.1002/pds.2136. Pharmacoepidemiol Drug Saf. 2011. PMID: 21448900

2

Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.

Smith JR, Rayner CR, Donner B, Wollenhaupt M, Klumpp K, Dutkowski R. Smith JR, et al. Adv Ther. 2011 Nov;28(11):927-59. doi: 10.1007/s12325-011-0072-7. Epub 2011 Nov 1. Adv Ther. 2011. PMID: 22057727 Free PMC article. Review.

3

Oseltamivir in human avian influenza infection.

Smith JR. Smith JR. J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii25-ii33. doi: 10.1093/jac/dkq013. J Antimicrob Chemother. 2010. PMID: 20215132 Free PMC article. Review.

4

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.

Smith JR, Sacks S. Smith JR, et al. Int J Clin Pract. 2009 Apr;63(4):596-605. doi: 10.1111/j.1742-1241.2009.02010.x. Int J Clin Pract. 2009. PMID: 19335705

5

Safety and pharmacokinetics of oseltamivir at standard and high dosages.

Dutkowski R, Smith JR, Davies BE. Dutkowski R, et al. Among authors: smith jr. Int J Antimicrob Agents. 2010 May;35(5):461-7. doi: 10.1016/j.ijantimicag.2009.12.023. Epub 2010 Mar 1. Int J Antimicrob Agents. 2010. PMID: 20189775 Clinical Trial.

6

The use of antiviral agents for the management of severe influenza.

Smith JR, Ariano RE, Toovey S. Smith JR, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Crit Care Med. 2010. PMID: 19935416 Review.

7

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

Ward P, Small I, Smith J, Suter P, Dutkowski R. Ward P, et al. J Antimicrob Chemother. 2005 Feb;55 Suppl 1:i5-i21. doi: 10.1093/jac/dki018. J Antimicrob Chemother. 2005. PMID: 15709056 Review.

8

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M. Stephenson I, et al. Clin Infect Dis. 2009 Feb 15;48(4):389-96. doi: 10.1086/596311. Clin Infect Dis. 2009. PMID: 19133796 Free article.

9

Oseltamivir effectiveness in seasonal influenza patients taking symptomatic therapy: retrospective analysis of RCT data.

Toovey S, Dutkowski R, Smith P, Smith JR. Toovey S, et al. Among authors: smith jr, smith p. Int J Clin Pharmacol Ther. 2013 Dec;51(12):932-41. doi: 10.5414/CP201888. Int J Clin Pharmacol Ther. 2013. PMID: 24120712 Clinical Trial.

10

Pharmacokinetics of oseltamivir in young and very elderly subjects.

Abe M, Smith J, Urae A, Barrett J, Kinoshita H, Rayner CR. Abe M, et al. Ann Pharmacother. 2006 Oct;40(10):1724-30. doi: 10.1345/aph.1H174. Epub 2006 Aug 29. Ann Pharmacother. 2006. PMID: 16940405 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,135 results

Search Page